Laurel Wealth Advisors, Inc. Tandem Diabetes Care Inc Transaction History

Laurel Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$53.22 - $123.09 $129,431 - $299,354	-2,432 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$101.89 - $150.09 $22,415 - $33,019	-220 Reduced 8.3%	2,432 $282,000
Q4 2021 Feb 14, 2022	BUY	$118.18 - $153.21 $313,413 - $406,312	2,652 New	2,652 $400,000
Q3 2021 Nov 12, 2021	SELL	$93.51 - $129.4 $246,118 - $340,580	-2,632 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$77.0 - $100.19 $202,664 - $263,700	2,632 New	2,632 $256,000

360

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.98B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Laurel Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Laurel Wealth Advisors, Inc. with notifications on news.